Has Carol Roach received payments from drug or device companies?

Yes. Drug and device makers reported $664 in general payments to Carol Roach across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carol Roach did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carol Roach come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carol Roach

Family · Reading, PANPI 1699826032

Payments from drug & device makers

$664in general payments, 2019–2025

Across 27 payments — averaging $24.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amarin Pharma, Inc.$243
Amgen$125
Abbott$95
Kowa Pharmaceuticals America, Inc.$94
Medtronic$44
Olympus America Inc.$22
plus $40 from 3 others

What the payments were for

Food & beverage$664100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amarin Pharma, Inc.	19	$243
Amgen	1	$125
Abbott	1	$95
Kowa Pharmaceuticals America, Inc.	1	$94
Medtronic	1	$44
Olympus America Inc.	1	$22
Biodelivery Sciences International, Inc.	1	$16
AbbVie	1	$15
Foundation Fusion Solutions, LLC	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Repatha$125

How this compares

$664 in reported general payments places this provider in the 65th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$57,260

Medicare patients

162

Services billed

1,352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
TrulicityDulaglutide	22	$30,677
BelbucaBuprenorphine Hcl	27	$21,064
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	378	$11,024
Buprenorphine	41	$8,799
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	227	$7,300
Fentanyl	29	$6,520
Morphine Sulfate ErMorphine Sulfate	241	$6,126
Eletriptan HbrEletriptan Hydrobromide	22	$5,227
Gabapentin	163	$4,147
Oxycodone Hcl	170	$3,896
Tramadol Hcl	326	$3,462
Lidocaine	11	$2,382
Pregabalin	100	$1,565
Diclofenac Sodium	68	$1,316
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine	19	$1,186

Paid to pharmacies, not to this prescriber.